Quest Diagnostics Incorporated

DGX

$173.53

Name : Quest Diagnostics Incorporated

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $19,404,722,176.00

EPSttm : 8.52

Quest Diagnostics Incorporated

$173.53

1.12%

$1.96

Float Short %

3.82

Margin Of Safety %

Put/Call OI Ratio

0.45

EPS Next Q Diff

-0.24

EPS Last/This Y

2.03

EPS This/Next Y

0.56

Price

173.44

Target Price

199.19

Analyst Recom

2.23

Performance Q

-4.69

Relative Volume

0.59

Beta

0.63

Ticker: DGX

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-02	DGX	182.47	0.74	2.47	10841
2025-12-03	DGX	182.64	0.79	6.45	11476
2025-12-04	DGX	184.14	0.85	2.93	11871
2025-12-05	DGX	182.5	0.85	1.23	11906
2025-12-08	DGX	181.32	0.84	0.25	11884
2025-12-09	DGX	179.61	0.84	0.76	11857
2025-12-10	DGX	179.41	0.85	0.17	11873
2025-12-11	DGX	181.59	0.85	0.11	11882
2025-12-12	DGX	182.55	0.85	2.68	11869
2025-12-15	DGX	184.14	0.87	0.50	12000
2025-12-16	DGX	178.54	0.87	3.05	12017
2025-12-17	DGX	178.95	0.91	1.33	12293
2025-12-18	DGX	176.11	0.89	60.31	12297
2025-12-19	DGX	176.05	0.76	0.57	11491
2025-12-22	DGX	176.26	0.42	0.58	8142
2025-12-23	DGX	175.08	0.43	3.43	8219
2025-12-26	DGX	175.97	0.45	0.09	8411
2025-12-29	DGX	175.51	0.45	0.05	8419
2025-12-30	DGX	175.56	0.45	0.27	8377
2025-12-31	DGX	173.45	0.45	4.17	8443
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-02	DGX	182.55	5.7	200.9	9.81
2025-12-03	DGX	182.61	5.7	210.5	9.81
2025-12-04	DGX	184.15	5.7	221.6	9.81
2025-12-05	DGX	182.51	5.7	197.6	9.81
2025-12-08	DGX	181.82	5.7	-	9.81
2025-12-09	DGX	179.62	5.7	193.4	9.81
2025-12-10	DGX	179.62	5.7	208.9	9.81
2025-12-11	DGX	181.57	5.7	226.4	9.81
2025-12-12	DGX	182.54	5.7	217.4	9.81
2025-12-15	DGX	184.11	5.7	221.8	9.81
2025-12-16	DGX	184.11	5.7	168.7	9.81
2025-12-17	DGX	179.08	5.7	213.3	9.81
2025-12-18	DGX	176.14	5.7	187.4	9.81
2025-12-19	DGX	175.99	5.7	208.8	9.81
2025-12-22	DGX	176.23	5.7	211.7	9.81
2025-12-23	DGX	174.82	5.7	198.3	9.81
2025-12-26	DGX	175.96	5.7	210.4	9.81
2025-12-29	DGX	175.54	5.7	206.9	9.81
2025-12-30	DGX	175.45	5.7	209.5	9.81
2025-12-31	DGX	173.44	5.7	194.1	9.81
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-02	DGX	-18.86	-1.00	3.88
2025-12-03	DGX	-18.86	-1.00	3.88
2025-12-04	DGX	-18.86	-1.00	3.88
2025-12-05	DGX	-18.86	-1.00	3.88
2025-12-08	DGX	-18.86	-1.08	3.88
2025-12-09	DGX	-18.86	-1.08	3.88
2025-12-10	DGX	-18.86	-1.08	3.88
2025-12-11	DGX	-18.86	-1.08	3.88
2025-12-12	DGX	-18.86	-1.08	3.88
2025-12-15	DGX	-18.86	-1.08	3.88
2025-12-16	DGX	-18.86	-1.08	3.88
2025-12-17	DGX	-18.86	-1.08	3.88
2025-12-18	DGX	-18.86	-1.08	3.88
2025-12-19	DGX	-18.86	-1.08	3.88
2025-12-22	DGX	-18.86	-1.19	3.88
2025-12-23	DGX	-18.86	-1.19	3.88
2025-12-26	DGX	-18.86	-1.19	3.82
2025-12-29	DGX	-18.86	-1.15	3.82
2025-12-30	DGX	-18.86	-1.15	3.82
2025-12-31	DGX	-18.86	-1.15	3.82
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

2.6

Avg. EPS Est. Current Quarter

2.36

Avg. EPS Est. Next Quarter

2.36

Insider Transactions

-18.86

Institutional Transactions

-1.15

Beta

0.63

Average Sales Estimate Current Quarter

2753

Average Sales Estimate Next Quarter

2757

Fair Value

221.98

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

12.2

Max Drawdown 5-Year %

-28.6

Target Price

199.19

P/E

20.36

Forward P/E

16.74

PEG

2.1

P/S

1.78

P/B

2.65

P/Free Cash Flow

13.86

EPS

8.52

Average EPS Est. Cur. Y

9.81

EPS Next Y. (Est.)

10.38

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

8.88

Relative Volume

0.59

Return on Equity vs Sector %

-14

Return on Equity vs Industry %

2.5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

194.1

Quest Diagnostics Incorporated

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 45000

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

stock quote shares DGX – Quest Diagnostics Incorporated Stock Price stock today

news today DGX – Quest Diagnostics Incorporated stock forecast ,stock prediction 2023 2024 2025

marketwatch DGX – Quest Diagnostics Incorporated yahoo finance google finance

stock history DGX – Quest Diagnostics Incorporated invest stock market

stock prices DGX premarket after hours

ticker DGX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: DGX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y